Umberto Pensato on Cancer and Stroke
Umberto Pensato, Assistant Professor of Neurology at the Humanitas University, Research Collaborator at the University of Calgary, shared on LinkedIn:
”Stroke in patients with cancer is common (1 every 7 patients), yet it is becoming extremely challenging to understand patient prognosis and goal-of-care, especially in the time-pressured environment of acute stroke care, resulting in missed/delayed acute treatment (not really in keeping with “Time is Brain”).
This is a call for oncologists, please provide upfront: (i)life expectancy (> or < 6 months?), (ii) goal-of-care (resuscitate, medical or comfort?), and (iii) intent of oncologist treatment (curative or palliative). Help us treat these patients better and faster
Take a look at our viewpoint in JAMA Oncology, Ronda Lun, Jeffrey Q Cao, and Andrew Demchuk, Humanitas University, University of Calgary”
Read the full article here.
Article: Stroke in Patients With Cancer—Time Is Brain
Authors: Ronda Lun, Jeffrey Q Cao, Andrew Demchuk, Umberto Pensato
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke